[247] identified a role for histone deacetylase 6 (HDAC6) in iCAFs in programming the immunosuppressive TME, where reducing HDAC6 in CAFs can alter the immunosuppressive breast cancer microenvironment by inhibiting MDSC and Treg recruitment and modulating macrophage phenotypes. This evidence concerns the gene HDAC6 and breast carcinoma.